Drug intelligence / Profile preview

testosterone undecanoate

Development stage: Approved
Lead developer: Endo International
Administration: Oral, Intramuscular

Overview

Testosterone undecanoate is an androgen and anabolic steroid used primarily for testosterone replacement therapy in adult males with conditions associated with low testosterone levels, such as primary or secondary hypogonadism. It acts as a prodrug of testosterone, providing strong androgenic effects and moderate anabolic effects. It is administered orally or via intramuscular injection. Common side effects include acne, increased hair growth, and elevated liver enzymes. It is also used off-label for physique and performance enhancement.

Brand names: NebidoAveedJatenzo
Other names: 十一酸睾酮

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on testosterone undecanoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on testosterone undecanoate.

Explore the full profile